10-Q Filing

APPLIED BIOSCIENCES CORP. CIK: 1607549 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001477932-16-013632`
Period End Date	20160930
Filing Date	20161117
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	fift-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 30 Income Statement 24 Cash Flow Statement 28

Balance Sheet 30 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$2.19K	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$1.50K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	10.00M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$1.50K	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$2.19K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	10.00M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	10.00M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	10.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.84K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$263.00	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$49.52K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$40.77K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$51.37K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$41.04K	USD	Point-in-time
Common stock (refer Note 3) Authorized 200,000,000 shares of common stock, $0.001 par value, Issued and outstanding 10,004,341 shares of common stock (March 31, 2016 10,004,341)	`CommonStockValue`	$10.00K	USD	Point-in-time
Common stock (refer Note 3) Authorized 200,000,000 shares of common stock, $0.001 par value, Issued and outstanding 10,004,341 shares of common stock (March 31, 2016 10,004,341)	`CommonStockValue`	$10.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$-1.91K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$-1.91K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-57.95K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-46.94K	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquity`	$-38.85K	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquity`	$-49.87K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.50K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$2.19K	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	-	USD	2 Qtrs
REVENUE	`Revenues`	-	USD	2 Qtrs
REVENUE	`Revenues`	-	USD	1 Quarter
REVENUE	`Revenues`	-	USD	1 Quarter
Office and general	`GeneralAndAdministrativeExpense`	$4.38K	USD	1 Quarter
Office and general	`GeneralAndAdministrativeExpense`	$15.42K	USD	2 Qtrs
Office and general	`GeneralAndAdministrativeExpense`	$6.40K	USD	1 Quarter
Office and general	`GeneralAndAdministrativeExpense`	$11.02K	USD	2 Qtrs
TOTAL EXPENSES	`OperatingExpenses`	$4.38K	USD	1 Quarter
TOTAL EXPENSES	`OperatingExpenses`	$15.42K	USD	2 Qtrs
TOTAL EXPENSES	`OperatingExpenses`	$11.02K	USD	2 Qtrs
TOTAL EXPENSES	`OperatingExpenses`	$6.40K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-6.40K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-4.38K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-15.42K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-11.02K	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF BASIC COMMON SHARES OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.00M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF BASIC COMMON SHARES OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.00M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF BASIC COMMON SHARES OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.00M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF BASIC COMMON SHARES OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	41.71M	shares	2 Qtrs

Cash Flow Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`NetIncomeLoss`	$-6.40K	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-4.38K	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-15.42K	USD	2 Qtrs
Net loss for the period	`NetIncomeLoss`	$-11.02K	USD	2 Qtrs
Expenses paid by related party	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	-	USD	2 Qtrs
Expenses paid by related party	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$8.75K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.58K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.77K	USD	2 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-11.64K	USD	2 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-690.00	USD	2 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.09K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from related parties	`ProceedsFromRelatedPartyDebt`	$8.55K	USD	2 Qtrs
Proceeds from related parties	`ProceedsFromRelatedPartyDebt`	-	USD	2 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$11.64K	USD	2 Qtrs
NET CHANGE IN CASH	`CashPeriodIncreaseDecrease`	-	USD	2 Qtrs
NET CHANGE IN CASH	`CashPeriodIncreaseDecrease`	$-690.00	USD	2 Qtrs
CASH, BEGINNING OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$2.19K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$1.50K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$2.19K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$1.50K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.